News
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
24m
News Medical on MSNCagrilintide and semaglutide together drive record weight loss in global trialA 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...
Cancer patients must speak to their doctor before taking weight-loss jabs, a British charity has warned, amid a rise in people seeking help over whether they can take them.Macmillan Cancer Support ...
Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results